MADM gives new insights into gliomagenesis

Por Lei, Liang, Canoll, Peter
Publicado em 2011

The interface between glial progenitors and gliomas

Por Canoll, Peter, Goldman, James E.
Publicado em 2008

Constitutive EGFR Signaling in Oligodendrocyte Progenitors Leads to Diffuse Hyperplasia in Postnatal White Matter

Por Ivkovic, Sanja, Canoll, Peter, Goldman, James E.
Publicado em 2008

Cell migration in the normal and pathological postnatal mammalian brain

Por Cayre, Myriam, Canoll, Peter, Goldman, James E.
Publicado em 2009

The cellular origin for malignant glioma and prospects for clinical advancements

Por Zong, Hui, Verhaak, Roel GW, Canoll, Peter
Publicado em 2012

MS-21 SUBEPENDYMOMAS DEMONSTRATE LINEAGE MARKERS SUGGESTING AN ORIGIN WITHIN MULTIPOTENTIAL PROGENITORS OF THE SUBVENTRICULAR ZONE

Por Praver, Moshe, D'Amico, Randy, Canoll, Peter, Bruce, Jeffrey
Publicado em 2014

CBMT-03. EVALUATION OF PET TRACERS TO DIFFERENTIATE IDH1 MUTANT GBM

Por Molotkov, Andrei, Mela, Angeliki, Canoll, Peter D, Mintz, Akiva
Publicado no Neuro Oncol (2019)

Convection-Enhanced Delivery for Targeted Delivery of Antiglioma Agents: The Translational Experience

Por Yun, Jonathan, Rothrock, Robert J., Canoll, Peter, Bruce, Jeffrey N.
Publicado em 2013

Convection-enhanced delivery for glioblastoma: targeted delivery of antitumor therapeutics

Por Ung, Timothy H, Malone, Hani, Canoll, Peter, Bruce, Jeffrey N
Publicado no CNS Oncol (2015)

HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer

Por David, Charles J., Chen, Mo, Assanah, Marcela, Canoll, Peter, Manley, James L.
Publicado em 2009

Retroviral Delivery of Platelet-Derived Growth Factor to Spinal Cord Progenitor Cells Drives the Formation of Intramedullary Gliomas

Por Ellis, Jason A., Castelli, Michael, Bruce, Jeffrey N., Canoll, Peter, Ogden, Alfred T.
Publicado em 2012

EGFR promoter exhibits dynamic histone modifications and binding of ASH2L and P300 in human germinal matrix and gliomas

Por Erfani, Parsa, Tome-Garcia, Jessica, Canoll, Peter, Doetsch, Fiona, Tsankova, Nadejda M
Publicado no Epigenetics (2015)

PATH-12. CHARACTERISTICS OF GIANT CELL MORPHOLOGY IN LONG-TERM SURVIVORS OF GLIOBLASTOMA: CONSIDERATION OF SEX DIFFERENCES

Por Johnston, Sandra, Bayless, Spencer, Mrugala, Maciej, Rubin, Joshua, Canoll, Peter, Swanson, Kristin
Publicado no Neuro Oncol (2018)

Glial Progenitors in Adult White Matter Are Driven to Form Malignant Gliomas by Platelet-Derived Growth Factor-Expressing Retroviruses

Por Assanah, Marcela, Lochhead, Richard, Ogden, Alfred, Bruce, Jeffrey, Goldman, James, Canoll, Peter
Publicado no J Neurosci (2006)

Pineal region glioblastomas display features of diffuse midline and non-midline gliomas.

Por D’Amico, Randy S., Zanazzi, George, Wu, Peter, Canoll, Peter, Bruce, Jeffrey N.
Publicado no J Neurooncol (2018)

The Role of Myosin II in Glioma Invasion of the Brain

Por Beadle, Christopher, Assanah, Marcela C., Monzo, Pascale, Vallee, Richard, Rosenfeld, Steven S., Canoll, Peter
Publicado em 2008

A Multi-Cancer Mesenchymal Transition Gene Expression Signature Is Associated with Prolonged Time to Recurrence in Glioblastoma

Por Cheng, Wei-Yi, Kandel, Jessica J., Yamashiro, Darrell J., Canoll, Peter, Anastassiou, Dimitris
Publicado em 2012

Biomarkers for glioma immunotherapy: the next generation

Por Sims, Jennifer S., Ung, Timothy H., Neira, Justin A., Canoll, Peter, Bruce, Jeffrey N.
Publicado no J Neurooncol (2015)

Convection Enhanced Delivery of Topotecan for Gliomas: A Single-Center Experience

Por Upadhyayula, Pavan S., Spinazzi, Eleonora F., Argenziano, Michael G., Canoll, Peter, Bruce, Jeffrey N.
Publicado no Pharmaceutics (2020)

Glial progenitor cell recruitment drives aggressive glioma growth: mathematical and experimental modelling

Por Massey, Susan Christine, Assanah, Marcela C., Lopez, Kim A., Canoll, Peter, Swanson, Kristin R.
Publicado em 2012